Hurthle Cell Carcinoma of the Thyroid
📧 Sign up to get email alerts when something new happens for Hurthle Cell Carcinoma of the Thyroid.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer [Phase 1]
Phase 1 clinical trial evaluating Lutetium-177 DOTA-EB-FAPI in patients with metastatic, radioiodine-refractory thyroid cancer has completed…
-
CLINICAL_TRIALS trial_result · 2023-10-24Clinical Trial Update: Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC) [Phase 2]
A Phase 2 trial evaluating the combination of lenvatinib and pembrolizumab in differentiated thyroid cancers has completed, with results pos…